U.S. awards contracts for bird flu vaccine | Chemical & Engineering News
Volume 85 Issue 4 | p. 18 | Concentrates
Issue Date: January 22, 2007

U.S. awards contracts for bird flu vaccine

Department: Business

The Department of Health & Human Services has awarded contracts totaling $132.5 million to three vaccine makers for the development of bird flu vaccines using an immune system booster, or adjuvant. HHS awarded five-year contracts to GlaxoSmithKline for $63.3 million and Novartis for $54.8 million. In addition, Iomai will receive $14.4 million, plus possible additional funding, to develop a vaccine patch. "In the event of an influenza pandemic, a vaccine that uses an adjuvant could provide a way to extend a limited vaccine supply," says HHS Secretary Michael O. Leavitt.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment